ASH Clinical News ACN_4.10_FULL ISSUE web | Page 7

VOLUME 04 | NUMBER 10 | AUGUST 2018 Around the Network AMERICAN SOCIETY OF HEMATOLOGY (ASH) HEADQUARTERS 2021 L Street NW, Suite 900 Washington, DC 20036 www.hematology.org Tel: [phone] IN THIS ISSUE pulling back the curtain Angela Thomas, OBE, PhD EDITOR-IN-CHIEF Mikkael Sekeres, MD, MS Dr. Thomas talks about mixing politics and medicine and defying expectations to chart her own career map. Vice-Chair for Clinical Research Director, Leukemia Program Cleveland Clinic, Taussig Cancer Institute Cleveland, OH 16 clinical news ASSOCIATE EDITORS 25 A Risk-Adapted, Chemotherapy-Alone Beth Faiman, CNP, PhD Approach for Early-Stage Hodgkin Lymphoma Cleveland Clinic Cleveland, OH Alice Ma, MD University of North Carolina School of Medicine Chapel Hill, NC David Steensma, MD Dana-Farber Cancer Institute Boston, MA Keith Stewart, MBChB, MBA Mayo Clinic Scottsdale, AZ Ad Nauseam The U.S. Food and Drug Administration has strict rules for direct-to-consumer pharmaceutical advertising, but, with new forms of sponsored content, drug companies are blurring the lines between advertisement and entertainment. ASH Clinical News spoke with researchers about the risks and benefits of direct-to-consumer advertising and the continuing debate about its regulation. 33 V  enetoclax Continues to Produce Deep Responses in CLL 34 O n Location: Highlights from the European Hematology Association’s 23rd Congress 44 PUBLISHER American Medical Communications (AMC) ASHCLINICALNEWS.ORG EDITORIAL MANAGING EDITORS Kristin Hubing, ASH Ariel Jones-DeMaio, AMC EDITORIAL ASSOCIATE Laurie Adamson, ASH ART DIRECTOR Ari Mihos ASSISTANT ART DIRECTORS Charlene DePrizio John Salesi DIGITAL PROJECTS MANAGER Chris Gedikli Want to hear more from the talented hematologists and oncologists we interview for our print issue? Visit ashclinicalnews.org/sound-bites to hear everything we couldn’t fit in print! Also, check out our daily updates from the world of hematology and health care in our “Online Exclusives,” with recent stories like: • Shortages Are Forcing Physicians and Pharmacists to Ration Opioids • EPA Blocks Report on Formaldehyde’s Cancer Risk @ASHCLINICALNEWS Make sure to follow us at @ASHClinicalNews for the latest updates in hematology! And don’t forget to sign up to receive our eNewsletters to have the latest updates from ASH Clinical News delivered to your inbox: ashclinicalnews.org/ enewsletter-sign-up. • CMS Cancels Agreement With Novartis to Pay for CAR T-Cell Treatment ADVERTISING ACCOUNT DIRECTORS Nick Luciano [email protected] Gene Conselyea [email protected] Sima Sherman [email protected] Recruitment advertising orders can be sent to: CLASSIFIEDS ACCOUNT MANAGER Lauren Morgan [email protected] Visit us at ashclinicalnews.org Follow us on Twitter @ASHClinicalNews A | S | B | P| E Fostering B2B editorial excellence American Society of Business Publication Editors 2018 National PR INT Gold ©2018 by the American Society of Hematology. All materials contained in this newsletter are protected by copy- right laws and may not be used, reproduced, or otherwise exploit- ed in any manner without the express prior written permission of ASH Clinical News. Any third-party materials communicated to ASH Clinical News become its copyrighted property and may be used, reproduced, or otherwise exploited by ASH Clinical News. ASHClinicalNews.org Visit ashclinicalnews.org/online-exclusive for more. “YOU MAKE THE CALL” WINNER Announcing last month’s “You Make the Call: Readers’ Response” winner: Michael Auerbach, MD Hope you enjoy your prize! For your chance to win, be sure to send in your response to each month's You Make the Call question! Subscription inquiries should be sent to: [email protected] All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036. Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated. No responsibility is assumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or otherwise or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer. About the American Society of Hematology The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH Clinical News (ISSN 2375-8120) is published monthly by American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. Periodicals postage paid at Freehold, NJ and additional mailing offices. POSTMASTER: Send address changes to American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. ©Copyright, 2018. ASH Clinical News 5